Dr. Feigin is Chief Medical Officer and a leading neurologist who brings 30 years of scientific excellence to Rho. A pioneer in clinical research, he’s led over 30 trials as site principal investigator and established renowned clinical trial programs for Parkinson’s, Huntington’s, Tourette syndrome, and other movement disorders. At Rho, he brings sharp insight and strategic savvy to the trials our team supports to maintain safety, integrity, and scientific rigor. Dr. Feigin is passionate about collaboration and innovation and sees Rho as the partner with the special combination of brainpower, quality, and teamwork to make an impact where it matters most.

With 25+ years of industry experience, Mr. Gordon has seen just about everything in clinical development. He can balance big-picture thinking with project level precision, which he combines with his knack for building strong relationships. Through operational strategy and executive level oversight, Mr. Gordon supports teams to ensure high-quality and timely program delivery. While he has background in CNS and pain trials, ADHD is where he has really left his mark, providing oversight of trial programs for at least 5 compounds. Mr. Gordon understands that clinical research can get complicated—but he makes it feel doable.

Ms. Lind has over 20 years of experience in clinical research leading complex, multi-phase clinical trials and development programs across asthma, allergic diseases, transplantation, and dermatology. From the beginning to the end of a trial, Ms. Lind knows how to make a study go, serving as the engine behind enrollment goals, timelines, regulatory standards, and budgets. She taps high-performing teams, manages complexity with ease, and keeps a meticulous eye on the details. Whether managing a single study or global portfolio, she ensures that every aspect of the trial is executed with precision and has optimal outcomes.